Publications

Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study.

PUNG, R; Clapham, HE; Russell, TW; CMMID COVID-19 Working Group,; Lee, VJ; KUCHARSKI, AJ;

2023

BMC medicine, (2023).21 1 10.1186/s12916-023-02802-0.

Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation.

Dodd, PJ; MCQUAID, CF; Rao, P; Abubakar, I; Arinaminpathy, N; Carnegie, A; Cobelens, F; Dowdy, D; Fiekert, K; GRANT, AD; Wu, J; Nfii, FN; Shaikh, N; HOUBEN, RM G J; WHITE, RG;

2023

International journal of epidemiology, (2023).52 6 10.1093/ije/dyad128.

Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.

Baede, VO; Gupta, A; KNIGHT, GM; Schouls, LM; Laing, K; Tavakol, M; Barray, A; De Vlas, SJ; De Vos, AS; Hendrickx, AP A; Khan, M; Kretzschmar, ME; Van Wamel, WJ B; Lina, G; Vandenesch, F; Vos, MC; Witney, AA; Rasigade, J-P; Lindsay, JA;

2023

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, (2023).29 9 10.1016/j.cmi.2023.05.015.

Emergence and pandemic spread of small ruminant lentiviruses.

Carrozza, M-L; Niewiadomska, A-M; Mazzei, M; Abi-Said, MR; Hué, S; Hughes, J; Gatseva, A; Gifford, RJ;

2023

Virus evolution, (2023).9 1 10.1093/ve/vead005.

The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis.

Millington, KA; WHITE, RG; Lipman, M; MCQUAID, CF; Hauser, J; Wooding, V; Potter, J; Abubakar, I; Wingfield, T;

2023

The Lancet. Respiratory Medicine, (2023).12 1 10.1016/S2213-2600(23)00409-5.

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.

AUZENBERGS, M; FU, H; ABBAS, K; PROCTER, SR; Cutts, FT; JIT, M;

2023

The Lancet. Global health, (2023).11 8 10.1016/S2214-109X(23)00220-6.

Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?.

Devlin, NJ; Pan, T; Sculpher, M; JIT, M; Stolk, E; Rowen, D; Van Hout, B; Norman, R;

2023

PharmacoEconomics, (2023).41 10 10.1007/s40273-023-01300-8.

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low- and middle-income countries: a modelling study.

FU, H; Abbas, K; Malvolti, S; Gregory, C; Ko, M; Amorij, J-P; JIT, M;

2023

medRxiv (2023). 10.1101/2023.03.10.23287067.

The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

Clark, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.09.27.23296211.

Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform.

The OpenSAFELY collaborative,; TAZARE, J; Nab, L; ZHENG, B; Hulme, W; Green, A; Curtis, H; MAHALINGASIVAM, V; Higgins, R; SCHULTZE, A; BHASKARAN, K; Mehrkar, A; Schaffer, A; Smith, R; Bates, C; Cockburn, J; Parry, J; Hester, F; Harper, S; EGGO, R; Walker, A; MARKS, M; Brown, M; MARINGE, C; LEYRAT, C; ... DOUGLAS, I.

2023

medRxiv (2023). 10.1101/2023.05.12.23289914.